Uwe Platzbecker
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS (NCT05829434) | Uwe Platzbecker | 2024-03-31 |
Track Uwe Platzbecker automatically
Every clearance here is in the API, with alerts when new ones post.